Want to join the conversation?
Robert W. Baird analyst Andrew Wittmann probes whether the $0.06 benefit from the tax item was included in the EPS. $ABM answers that roughly $0.06 is included in adjusted EPS mainly related to an early adoption of an accounting spending tied to stock-based compensation. The majority of the other discrete items was roughly $0.32 at the end of 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?